SCHEMBL525652

SCHEMBL525652

COc1cc2c(cc1OC)CNC=C2

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.45
MAPT P10636 1/20 0.45
BRD4 O60885 1/20 0.42
PARP1 P09874 1/20 0.41
ALDH1A1 P00352 5/20 0.41
MAOA P21397 5/20 0.40
KDM4E B2RXH2 3/20 0.40
GLA P06280 2/20 0.40
TSHR P16473 1/20 0.35
CHRNA7 P36544 1/20 0.34
MAOB P27338 1/20 0.34
SLC6A4 P31645 1/20 0.34
KMT2A Q03164 2/20 0.34
RAB9A P51151 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4762831 0.98 PARP1 (0.44) CYP3A4MAPTBRD4PARP1ALDH1A1
SCHEMBL3821050 0.86 PARP1 (0.37) CYP3A4MAPTBRD4PARP1ALDH1A1
SCHEMBL29561779 0.81 MAOA (0.45) CYP3A4MAPTBRD4ALDH1A1MAOA
SCHEMBL10650554 0.81 MAOA (0.45) CYP3A4MAPTBRD4ALDH1A1MAOA
SCHEMBL19038489 0.74 GAA (0.58) MAPTPARP1ALDH1A1MAOAKDM4E
SCHEMBL333847 0.72 GAA (0.63) CYP3A4MAPTBRD4ALDH1A1MAOA
SCHEMBL11044416 0.72 BRD4 (0.45) CYP3A4MAPTBRD4ALDH1A1MAOA
SCHEMBL3903265 0.69 CYP3A4 (0.50) CYP3A4MAPTBRD4ALDH1A1MAOA
SCHEMBL28122218 0.68 PDE3A (0.34) PARP1
SCHEMBL1705264 0.68 CYP3A4 (0.59) CYP3A4MAPTALDH1A1MAOAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 WO disclosed
CN-109456268-A The preparation of 3, the 4- dihydro-isoquinoline Alkaloid of C1 substitutions and its medical usage 中国药科大学 2019-03-12 CN disclosed
WO-2013116491-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS AND METHODS FOR USING THEM RIGEL PHARMACEUTICALS, INC. (US) 2013-08-08 WO disclosed
EP-2598483-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2013-06-05 EP disclosed
WO-2012016217-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 WO disclosed
EP-2391616-A1 CARBOXAMIDE COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2011-12-07 EP disclosed
WO-2010088392-A1 CARBOXAMIDE COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2010-08-05 WO disclosed
CN-101208305-A 3,4-dihydroisoquinolinium salt derivatives HANWHA CHEMICAL CORP (KR) 2008-06-25 CN disclosed
EP-1896419-A1 3,4-DIHYDROISOQUINOLINIUM SALT DERIVATIVES HANWHA CHEMICAL CORPORATION (KR) 2008-03-12 EP disclosed
CN-1310915-C Pyrido(2,1-a)isoquinoline derivatives as DPP-IV inhibitors HOFFMANN LA ROCHE (CH) 2007-04-18 CN disclosed
WO-2006129978-A1 3,4-DIHYDROISOQUINOLINIUM SALT DERIVATIVES HANWHA CHEMICAL CORPORATION (KR) 2006-12-07 WO disclosed
CN-1639162-A Pyrido(2,1-a)isoquinoline derivatives as DPP-IV inhibitors HOFFMANN LA ROCHE (CH) 2005-07-13 CN disclosed
EP-1091960-A1 BIFUNCTIONAL ANTAGONISTS OF CYTOKINE-SENSITIVE PROTEIN KINASE ACTIVATION CASCADES AND METHODS FOR USE AS ANTI-INFLAMMATORY AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-04-18 EP disclosed
CN-1262677-A Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents UNIV AUSTRALIAN (AU) 2000-08-09 CN disclosed
WO-2000000491-A1 BIFUNCTIONAL ANTAGONISTS OF CYTOKINE-SENSITIVE PROTEIN KINASE ACTIVATION CASCADES AND METHODS FOR USE AS ANTI-INFLAMMATORY AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-01-06 WO disclosed
EP-0801568-A4 COMPOUNDS FOR INHIBITION OF CERAMIDE-MEDIATED SIGNAL TRANSDUCTION UNIV CALIFORNIA (US) 1998-02-25 EP disclosed
EP-0801568-A1 COMPOUNDS FOR INHIBITION OF CERAMIDE-MEDIATED SIGNAL TRANSDUCTION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-10-22 EP disclosed
WO-1996020710-A1 COMPOUNDS FOR INHIBITION OF CERAMIDE-MEDIATED SIGNAL TRANSDUCTION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-07-11 WO disclosed
EP-0158312-B1 1-CYCLOHEXYL-3,4-DIHYDROISOQUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENT CONTAINING THEM RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1990-09-12 EP disclosed